Newsroom

COPENHAGEN, Denmark--(BUSINESS WIRE)--Cadeler today announces that it has signed firm contracts with COSCO Shipping Offshore shipyard in Qidong, China, for the construction of two new T-class offshore wind installation vessels, scheduled for delivery in 2030 and 2031. Earlier this year, Cadeler secured the equity financing for this investment as part of its long-term strategy to become the preferred offshore wind installation partner and to support the continued growth of the offshore wind indu...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 07.08.2026 EDVY.LN IE000CPG9HG3   50,002.00 EUR   1,163,087.15   23.261  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 07.08.2026 MDEC.LN IE0007FIJUO5   50,002.00 USD   1,420,889.20   28.417  ...

LONDON--(BUSINESS WIRE)--Paysafe (NYSE: PSFE), PaysafeWallet has arrived in Poland and it’s built for a new generation. Polish consumers can now access a digital wallet giving them their own personal debit card, on their phone, built for the way they live, spend and have fun today. Poland has strong adoption of PaysafeCard, and this builds on that foundation. PaysafeWallet extends what customers already trust into a broader, more complete wallet experience. With PaysafeWallet, everything is in...

TAIPEI, Taiwan--(BUSINESS WIRE)--OCP APAC SUMMIT -- Insyde® Software, a worldwide provider of UEFI and OpenBMC firmware for AI Infrastructure, today announced that InsydeH2O® UEFI firmware is qualified on Arm® AGI CPU reference platforms, giving platform developers a proven, production-ready firmware foundation for next-generation agentic AI data center deployments. In addition, Insyde has readied its production verified Supervyse® OPF OpenBMC firmware for Arm AGI CPU-based AI server racks. Thi...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that, subject to the closing of its strategic partnership with Sobi, it plans to initiate the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma (CTCL). Innate also announced the appointment of Markus Jensen as Chief Medical Officer and member of the Executive Leadership Team, effective September 1, 2026, succeeding So...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que, sous réserve de la clôture de son partenariat stratégique avec Sobi, elle prévoit d’initier l’étude confirmatoire de Phase 3 TELLOMAK-3 évaluant lacutamab dans le lymphome T cutané (CTCL). Innate annonce également la nomination de Markus Jensen au poste de Directeur médical, membre de l’équipe de direction exécutive, à compter du 1e...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 7 August 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 7 August 2026 Number of Public Shares Purchased: 30,175...

NEW YORK & PARIS--(BUSINESS WIRE)--OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has signed a definitive agreement to acquire Maersk Training and its subsidiary Maersk H2S Safety Services. The company, a provider of global safety training and gas safety services, is being carved out from A.P. Møller - Mærsk A/S (MAERSK A:CPH), a listed integrated logistics company. Headquartered in Svendborg, Denmark, Maersk Training is a leading global provider of essenti...

BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology based in Barcelona, today announced a collaboration and licensing agreement with Shenzhen CrystalO Biopharma Technology Co., Ltd. ("CrystalO") to jointly initiate an R&D collaboration for drug discovery in medical dermatology. The collaboration will combine CrystalO's scientific expertise in ion channels with Almirall's experience in medical dermatology research and c...